Methods for the treatment of dysmyelinating/demyelinating diseases

Abstract

Provided herein are methods of treating a dysmyelinating/demyelinating disease or condition in a patient in need thereof. The methods comprise restoring Qki-PPARβ-RXRα-dependent lipid metabolism in myelin. For example, the methods comprise administering a PPARβ agonist or an RXR agonist to the …